SEC Stock Data Quick Answer ALNYLAM PHARMACEUTICALS, INC. reported Revenue (ASC 606) of $3.71 billion for fiscal year 2025. ALNYLAM PHARMACEUTICALS, INC. Revenue (ASC 606) — Annual History Fiscal Year Revenue (ASC 606) YoY Change 2025 $3.71B +65.2% 2024 $2.25B +23.0% 2023 $1.83B +76.2% 2022 $1.04B +22.9% 2021 $844.29M +71.3% 2020 $492.85M +124.3% 2019 $219.75M +193.4% 2018 $74.91M … Read more
Quick Answer ALNYLAM PHARMACEUTICALS, INC. reported Total Revenue of $3.71 billion for fiscal year 2025. ALNYLAM PHARMACEUTICALS, INC. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $3.71B +65.2% 2024 $2.25B +23.0% 2023 $1.83B +76.2% 2022 $1.04B +22.9% 2021 $844.29M +71.3% 2020 $492.85M +124.3% 2019 $219.75M +193.4% 2018 $74.91M +2483.0% 2017 $2.90M … Read more
Quick Answer ALNYLAM PHARMACEUTICALS, INC. reported Total Revenue of $3.71 billion for fiscal year 2025. ALNYLAM PHARMACEUTICALS, INC. — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $3.71B+65.2% $2.25B+23.0% $1.83B+76.2% $1.04B+22.9% $844.29M+71.3% $492.85M+124.3% Revenue (ASC 606) $3.71B+65.2% $2.25B+23.0% $1.83B+76.2% $1.04B+22.9% $844.29M+71.3% $492.85M+124.3% Net Income $313.75M+212.8% -$278.16M+36.8% -$440.24M+61.1% -$1.13B-32.6% -$852.82M+0.6% -$858.28M+3.1% … Read more
Quick Answer ALLIENT INC reported Shares Outstanding of 16.94 million shares for fiscal year 2025. ALLIENT INC Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 16.94M +0.7% 2024 16.81M +3.1% 2023 16.31M +2.1% 2022 15.98M +4.0% 2021 15.36M +5.0% 2020 14.63M +52.4% 2019 9.60M +1.2% 2018 9.48M +100515.3% 2017 9,427 +0.6% … Read more
Quick Answer ALLIENT INC reported Gross Profit of $181.71 million for fiscal year 2025. ALLIENT INC Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $181.71M +9.7% 2024 $165.69M -9.8% 2023 $183.68M +16.8% 2022 $157.26M +29.9% 2021 $121.06M +11.5% 2020 $108.58M -3.6% 2019 $112.58M +23.2% 2018 $91.40M +20.8% 2017 $75.68M +3.7% 2016 … Read more
Quick Answer ALLIENT INC reported Operating Income of $43.98 million for fiscal year 2025. ALLIENT INC Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 $43.98M +46.4% 2024 $30.04M -29.0% 2023 $42.31M +33.7% 2022 $31.66M +21.6% 2021 $26.03M +13.2% 2020 $22.99M -21.9% 2019 $29.44M +26.8% 2018 $23.23M +23.6% 2017 $18.80M -0.4% 2016 … Read more
Quick Answer ALLIENT INC reported Stockholders Equity of $301.45 million for fiscal year 2025. ALLIENT INC Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $301.45M +13.8% 2024 $264.85M +5.3% 2023 $251.57M +16.8% 2022 $215.47M +14.8% 2021 $187.76M +31.3% 2020 $143.06M +20.0% 2019 $119.19M +17.1% 2018 $101.81M +16.6% 2017 $87.35M +20.8% 2016 … Read more
Quick Answer ALLIENT INC reported Long-Term Debt of $180.39 million for fiscal year 2025. ALLIENT INC Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $180.39M -19.5% 2024 $224.18M +2.6% 2023 $218.40M -7.2% 2022 $235.45M +48.1% 2021 $158.96M +32.4% 2020 $120.08M +9.4% 2019 $109.77M -10.4% 2018 $122.52M +132.5% 2017 $52.69M -25.2% 2016 … Read more
Quick Answer ALLIENT INC reported Cash and Equivalents of $40.70 million for fiscal year 2025. ALLIENT INC Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $40.70M +12.7% 2024 $36.10M +13.2% 2023 $31.90M +4.2% 2022 $30.61M +36.3% 2021 $22.46M -2.9% 2020 $23.13M +72.4% 2019 $13.42M +54.7% 2018 $8.67M -44.4% 2017 … Read more
Quick Answer ALLIENT INC reported Total Assets of $577.60 million for fiscal year 2025. ALLIENT INC Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $577.60M +0.3% 2024 $575.78M -3.6% 2023 $597.54M +1.6% 2022 $588.35M +25.0% 2021 $470.79M +34.8% 2020 $349.20M +14.2% 2019 $305.83M +7.2% 2018 $285.30M +51.8% 2017 $187.92M +4.4% 2016 … Read more